NCT04142411

Brief Summary

Carpal tunnel syndrome (CTS) is the most common peripheral entrapment neuropathy with involving compression of the median nerve in the carpal tunnel. The technique of perineural injection therapy (PIT) is now commonly used for peeling the nerve from surrounding soft tissue (called nerve hydrodissection), which may help to reduce neuro-inflammation, ischemic damage and allow impulse transmission. The objective of this study is to evaluate the efficacy of ultrasound guided insulin plus Sodium Hyaluronate injection in reducing symptoms caused by carpal tunnel syndrome.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Nov 2019

Shorter than P25 for early_phase_1

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 18, 2019

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 29, 2019

Completed
3 days until next milestone

Study Start

First participant enrolled

November 1, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2020

Completed
Last Updated

October 29, 2019

Status Verified

October 1, 2019

Enrollment Period

6 months

First QC Date

October 18, 2019

Last Update Submit

October 25, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Boston Carpal Tunnel Syndrome Questionnaire - Symptom Severity Scale

    Boston carpal tunnel syndrome questionnaire - SSS is patient-based questionnaire for measurement of CTS severity which include11 questions to evaluate the symptom severity. Each question ranges from 1 to 5 with a higher score indicating a higher degree of disability.

    Baseline, 1 month, 3 months

Secondary Outcomes (6)

  • Boston Carpal Tunnel Syndrome Questionnaire - Functional Status Scale

    Baseline, 1 month, 3 months

  • Neuropathic pain Visual Analog Scale (VAS)

    Baseline, 1 month, 3 months

  • U/S measured medial nerve mean CSA

    Baseline, 1 month, 3 months

  • U/S measured medial nerve CSA difference

    Baseline, 1 month, 3 months

  • U/S hyper-vascularization of medial nerve percentage

    Baseline, 1 month, 3 months

  • +1 more secondary outcomes

Other Outcomes (1)

  • Patient satisfaction (Likert scale)

    1month, 3 months

Study Arms (3)

Insulin and Sodium Hyaluronate Ultrasound guided injection

EXPERIMENTAL

Subjects will receive Ultrasound guided injection of 10 IU of crystalline insulin and 20 mg of Sodium Hyaluronate

Drug: InsulinDrug: Sodium HyaluronateDevice: Ultrasound

Insulin Ultrasound guided injection

ACTIVE COMPARATOR

Subjects will receive Ultrasound guided injection of 10 IU of crystalline insulin

Drug: InsulinDevice: Ultrasound

Sodium Hyaluronate Ultrasound guided injection

ACTIVE COMPARATOR

Subjects will receive Ultrasound guided injection of 20 mg of Sodium Hyaluronate

Drug: Sodium HyaluronateDevice: Ultrasound

Interventions

Ultrasound guided perineural injection therapy (PIT)

Also known as: Crystalline Insulin
Insulin Ultrasound guided injectionInsulin and Sodium Hyaluronate Ultrasound guided injection

Ultrasound guided perineural injection therapy (PIT)

Also known as: Hyalgan
Insulin and Sodium Hyaluronate Ultrasound guided injectionSodium Hyaluronate Ultrasound guided injection

Philips Neuromuscular Ultrasound

Insulin Ultrasound guided injectionInsulin and Sodium Hyaluronate Ultrasound guided injectionSodium Hyaluronate Ultrasound guided injection

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 to 65
  • Understanding written and spoken Arabic consent
  • Diagnostic of carpal tunnel syndrome: Classic of probable based on the Katz Hand Diagram and mild to moderate based on the electrodiagnosis studies

You may not qualify if:

  • Diseases known to cause carpal tunnel syndrome: Diabetes mellitus, hypothyroidism, connective tissue disease, rheumatic disease and moderate or severe chronic renal impairment
  • Secondary diagnosis based on the ultrasound: arthrosynovial cyst, flexor tenosynovitis, ganglion
  • Constant symptoms in medial nerve area
  • Thenar eminence atrophy
  • Cervical radiculopathy
  • Brachial plexopathy
  • Thoracic outlet syndrome
  • Polyneuropathy
  • Pregnancy
  • Cognitive disorder
  • Anticoagulant therapy
  • Carpal tunnel injection in the last 6 months
  • Ancient ipsilateral wrist fracture
  • Ancient ipsilateral wrist surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medicine

Asyut, 71111, Egypt

Location

Related Publications (4)

  • Smith J, Wisniewski SJ, Finnoff JT, Payne JM. Sonographically guided carpal tunnel injections: the ulnar approach. J Ultrasound Med. 2008 Oct;27(10):1485-90. doi: 10.7863/jum.2008.27.10.1485.

    PMID: 18809959BACKGROUND
  • Kamel SR, Sadek HA, Hamed A, Sayed OA, Mahmud MH, Mohamed FA, El Sagher GM, Aly LH. Ultrasound-guided insulin injection for carpal tunnel syndrome in type 2 diabetes mellitus patients. Clin Rheumatol. 2019 Oct;38(10):2933-2940. doi: 10.1007/s10067-019-04638-7. Epub 2019 Jun 17.

    PMID: 31209710BACKGROUND
  • Apel PJ, Ma J, Callahan M, Northam CN, Alton TB, Sonntag WE, Li Z. Effect of locally delivered IGF-1 on nerve regeneration during aging: an experimental study in rats. Muscle Nerve. 2010 Mar;41(3):335-41. doi: 10.1002/mus.21485.

    PMID: 19802878BACKGROUND
  • Ten Broek RPG, Stommel MWJ, Strik C, van Laarhoven CJHM, Keus F, van Goor H. Benefits and harms of adhesion barriers for abdominal surgery: a systematic review and meta-analysis. Lancet. 2014 Jan 4;383(9911):48-59. doi: 10.1016/S0140-6736(13)61687-6. Epub 2013 Sep 27.

    PMID: 24075279BACKGROUND

MeSH Terms

Conditions

Carpal Tunnel Syndrome

Interventions

InsulinHyaluronic AcidUltrasonography

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and Injuries

Intervention Hierarchy (Ancestors)

ProinsulinInsulinsPancreatic HormonesPeptide HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsPeptidesAmino Acids, Peptides, and ProteinsGlycosaminoglycansPolysaccharidesCarbohydratesDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Khaled O Aboshaera, MD

    Assistant Professor

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Khaled O Aboshaera, MD

CONTACT

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 18, 2019

First Posted

October 29, 2019

Study Start

November 1, 2019

Primary Completion

May 1, 2020

Study Completion

August 1, 2020

Last Updated

October 29, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share

Locations